KKUR Stock Overview
ChromoCure, Inc. develops and provides proprietary cancer detection systems.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
ChromoCure, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000002 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 100.00% |
| 3 Month Change | 100.00% |
| 1 Year Change | 100.00% |
| 3 Year Change | -98.00% |
| 5 Year Change | 100.00% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| KKUR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 100.0% | -4.4% | -3.7% |
| 1Y | 100.0% | -2.8% | 20.2% |
Return vs Industry: KKUR exceeded the US Medical Equipment industry which returned -2.2% over the past year.
Return vs Market: KKUR exceeded the US Market which returned 20.5% over the past year.
Price Volatility
| KKUR volatility | |
|---|---|
| KKUR Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: KKUR's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine KKUR's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | n/a | n/a |
ChromoCure, Inc. develops and provides proprietary cancer detection systems. The company offers Chromosomal Scanner Series 200, a cancer detection system to measure the genomic characteristic found in 100% of all cancers and never found in normal cells. It also applies its science and technology to non-toxic and non-invasive approaches to cancer therapy and cure research.
ChromoCure, Inc. Fundamentals Summary
| KKUR fundamental statistics | |
|---|---|
| Market cap | US$16.40k |
| Earnings (TTM) | -US$147.24k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio0.0x
P/E RatioIs KKUR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KKUR income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$147.24k |
| Earnings | -US$147.24k |
Last Reported Earnings
Dec 31, 2009
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did KKUR perform over the long term?
See historical performance and comparison